The Gut-Restricted IBD Solution

Quality of life should get as much attention as disease management

Improving drug tolerability is the cornerstone of our research strategy

Treatment-associated side effects have a significant impact on quality of life and treatment adherence.

In the context of a life-long medical condition such as IBD, addressing potential tolerability issues becomes even more critical.

Giiant Pharma: We Make Small Molecules

About Us

Primum non nocere - "First do no harm"

About IBD

The challenge remains: cure and care

The Science

High precision colonic delivery